We are live on ! Find out more
BCYC

Bicycle Therapeutics

105 hedge funds and large institutions have $884M invested in Bicycle Therapeutics in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 42 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more call options, than puts

Call options by funds: $28.8M | Put options by funds: $6.85M

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

4% more funds holding

Funds holding: 101105 (+4)

5.21% less ownership

Funds ownership: 73.35%68.15% (-5.2%)

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

33% less capital invested

Capital invested by funds: $1.31B → $884M (-$427M)

36% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 42

Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
1.66%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
24
Increased
27
Reduced
42
Closed
20
Calls
$28.8M
Puts
$6.85M
Net Calls
+$21.9M
Net Calls Change
+$20.9M
Name Holding Trade Value Shares
Change
Change in
Stake
ZIG
101
Zullo Investment Group
Pennsylvania
$2K
Carson Wealth (CWM LLC)
102
Carson Wealth (CWM LLC)
Nebraska
$1K +$1.31K +28 New
Kayne Anderson Rudnick Investment Management
103
Kayne Anderson Rudnick Investment Management
California
$1K +$1.4K +30 New
RCI
104
Ridgeback Capital Investments
Florida
-$132M -2,164,801 Closed
FM
105
Frazier Management
Washington
-$33.8M -555,240 Closed
Citadel Advisors
106
Citadel Advisors
Florida
-$2.72M -58,187 Closed
Voloridge Investment Management
107
Voloridge Investment Management
Florida
-$3.2M -52,575 Closed
GCM
108
Goldstream Capital Management
Hong Kong
-$2.94M -48,257 Closed
LCM
109
Laurion Capital Management
New York
-$1.91M -31,410 Closed
CP
110
Castleview Partners
Texas
-$258 -15,704 Closed
SCM
111
Soleus Capital Management
Connecticut
-$624K -10,250 Closed
Wells Fargo
112
Wells Fargo
California
-$365K -6,001 Closed
TI
113
Trexquant Investment
Connecticut
-$266K -4,370 Closed
SFI
114
Susquehanna Fundamental Investments
Pennsylvania
-$256K -4,200 Closed
SEI Investments
115
SEI Investments
Pennsylvania
-$229K -3,760 Closed
DCM
116
Difesa Capital Management
New York
-$213K -3,500 Closed
COPPSERS
117
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$205K -3,373 Closed
Northern Trust
118
Northern Trust
Illinois
-$177K -2,905 Closed
Simplex Trading
119
Simplex Trading
Illinois
-$72.7K -1,557 Closed
SFM
120
Signet Financial Management
New Jersey
-$40K -665 Closed
QT
121
Quantbot Technologies
New York
-$34K -559 Closed
ACM
122
Absolute Capital Management
Pennsylvania
-$4.26K -70 Closed
MP
123
McDonald Partners
Ohio
-$4.26K -70 Closed
MAM
124
Meeder Asset Management
Ohio
+$93 +2 New

BCYC Hedge Fund Activity: Q1 2022 in Review

105 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2022, worth a combined $884M — down 33% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BCYC positions and 20 closed out — a net gain of 4 holders — while 27 added to existing stakes and 42 trimmed.

The largest buyer was Deep Track Capital, adding an estimated $35.3M. The largest seller was Tybourne Capital Management, cutting an estimated $42M.

  • 105 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2022, up from 101 in Q4 2021.
  • Funds reported $884M of Bicycle Therapeutics stock for Q1 2022, down 33% quarter-over-quarter.
  • 24 funds opened new Bicycle Therapeutics positions in Q1 2022 and 20 closed out, a net change of +4 holders.
  • The largest Bicycle Therapeutics buyer in Q1 2022 was Deep Track Capital, an estimated $35.3M added.
  • The largest Bicycle Therapeutics seller in Q1 2022 was Tybourne Capital Management, an estimated $42M sold.

Based on aggregated 13F filings for Q1 2022.